| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |